This report contains market size and forecasts of Dengue Virus Diagnostic Tests in China, including the following market information:
China Dengue Virus Diagnostic Tests Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Dengue Virus Diagnostic Tests companies in 2020 (%)
The global Dengue Virus Diagnostic Tests market size is expected to growth from US$ 3250.3 million in 2020 to US$ 4188 million by 2027; it is expected to grow at a CAGR of 3.6% during 2021-2027.
The China Dengue Virus Diagnostic Tests market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Dengue Virus Diagnostic Tests Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Dengue Virus Diagnostic Tests Market,

By Type

, 2016-2021, 2022-2027 ($ Millions)
China Dengue Virus Diagnostic Tests Market Segment Percentages,

By Type

, 2020 (%)
Dengue NS1Ag Test
Dengue IgG/IgM Test
Dengue NS1 Ag-IgG/IgM Test

China Dengue Virus Diagnostic Tests Market,

By Application

, 2016-2021, 2022-2027 ($ Millions)
China Dengue Virus Diagnostic Tests Market Segment Percentages,

By Application

, 2020 (%)
Hospital
Research Institution
Others

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dengue Virus Diagnostic Tests revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Dengue Virus Diagnostic Tests revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Alere
Biogate
NovaBios Laboratories Diagnostics
Rapikit
Wondfo
BTNX
GENESIS
Boson Biotech
Adaltis
AccuBio Tech
Mediven
NTBIO